Cresset Asset Management’s Artivion AORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-17,800
Closed -$438K 1453
2025
Q1
$438K Sell
17,800
-330
-2% -$9.17K ﹤0.01% 1134
2024
Q4
$518K Sell
18,130
-19,929
-52% -$553K ﹤0.01% 1067
2024
Q3
$1.01M Buy
38,059
+5,539
+17% +$144K ﹤0.01% 1160
2024
Q2
$834K Sell
32,520
-491
-1% -$11K ﹤0.01% 1170
2024
Q1
$699K Buy
33,011
+15,000
+83% +$279K ﹤0.01% 1171
2023
Q4
$322K Buy
+18,011
New +$280K ﹤0.01% 1454
2019
Q2
Sell
-4
Closed 543
2019
Q1
$0 Buy
+4
New +$114 ﹤0.01% 1976

Other funds holding AORT

Cresset Asset Management's AORT Position: Q2 2025 in Review

Cresset Asset Management sold out of Artivion (AORT) in Q2 2025, closing a stake of 17,800 shares — an estimated $438K sold.

Cresset Asset Management first reported a position in AORT in Q1 2019 and held it in 7 quarters. The position peaked at $1.01M in Q3 2024. 188 funds tracked by Wall St. Rank hold AORT as of Q2 2025.

  • Cresset Asset Management reported no remaining Artivion position as of Q2 2025 after selling out during the quarter.
  • Cresset Asset Management sold 17,800 Artivion shares in Q2 2025, an estimated $438K.
  • Cresset Asset Management first reported a position in Artivion in Q1 2019 and held it in 7 quarters.
  • Cresset Asset Management's Artivion position peaked at $1.01M in Q3 2024.
  • 188 funds tracked by Wall St. Rank held Artivion as of Q2 2025.

Based on Cresset Asset Management's 13F filing for Q2 2025, filed 13 Aug 2025.